Journals / Ankara Medical Journal / 2019 / Cilt: 19 - Sayı: 2

Are There Any Differences in Clinicopathological Features of Thyroid Cancer Between Diabetic and Non‐Diabetic Patients?

Diyabetik Hastalarda Tiroid Kanserlerinin Klinikopatolojik Özellikleri Non‐diyabetik Hastalardan Farklı mıdır?

Pages
278–287
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Median age was higher in diabetic patients [59 (25‐81) years, 48 (19‐84) years; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Although there are numerous studies about the relationship between diabetes mellitus and thyroid cancer, there are few studies about the clinicopathological features in diabetic patients with thyroid cancer.
📊
Key Findings & Data:Materials and Methods: Data of patients who underwent thyroidectomy between 2007‐2014 were reviewed retrospectively.
💡
Conclusion & Impact:Median age was higher in diabetic patients [59 (25‐81) years, 48 (19‐84) years; p
🔬Design:Review & Systematic Survey
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Although there are numerous studies about the relationship between diabetes mellitus and thyroid cancer, there are few studies about the clinicopathological features in diabetic patients with thyroid cancer. Our aim is to evaluate whether ultrasonographic and cytopathological features of malignant nodules and distribution of thyroid cancer and its variants are different in diabetic and non‐diabetic patients. Materials and Methods: Data of patients who underwent thyroidectomy between 2007‐2014 were reviewed retrospectively. Patients with cyto‐histopathological data were included. Hormonal, ultrasonographic, and cyto‐histopathologic features of diabetic and non‐diabetic patients were compared. Results: Of 865 patients, 113 were diabetic (13.06%). Median age was higher in diabetic patients [59 (25‐81) years, 48 (19‐84) years; p

Özet

Amaç: Diyabetes mellitus ve tiroid kanseri arasında ilişki olup olmadığı ile ilgili yapılmış çok sayıdaçalışma olmasına rağmen diyabetik hastalardaki tiroid kanserinin klinikopatolojik özellikleri ile ilgiliçok az sayıda çalışma mevcuttur. Bu çalışmadaki amacımız diyabetik hastalarda malign nodüllerinultrasonografik özellikler, sitolojik özellikler ve tiroid kanseri tiplerinin dağılımı açısından non‐diyabetik hastalara göre farklılık olup olmadığının tespit edilmesidir.Materyal ve Metot: 2007‐2014 yılları arasında tiroidektomi yapılan hastalar retrospektif olaraktarandı. Sitolojik ve histopatolojik verileri tam olan hastalar çalışmaya dahil edildi. Hastalar diyabetikve non‐diyabetik olarak ayrıldı. Demografik, hormonal, ultrasonografik, sitolojik ve histopatolojiközellikler karşılaştırıldı.Bulgular: Toplam 865 hastanın 113’ü diyabetikti (% 13,06). Diyabetiklerde yaş ortancası daha fazlaydı[59 (25‐81), 48 (19‐84); p

🔖

Cite This Article

ÇAKIR, B., ERSOY, R., DELLA, F. D., POPLAT, Ş. B., YAZICIOĞLU, M. Ö., DOĞAN, H. T. (2022). Are There Any Differences in Clinicopathological Features of Thyroid Cancer Between Diabetic and Non‐Diabetic Patients?. Ankara Medical Journal, Cilt: 19 - Sayı: 2, 278–287. https://ajindex.com/articles/441878

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973‐2002. Cancer Causes Control. 2009;20(5):525‐31
  2. Busco S, Paolo GR, Isabella S, Pezzotti P, Buzzoni C, Pannozzo F. Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical disease. Cancer Epidemiol 2013;37:262‐9
  3. Yeo Y, Ma SH, Hwang Y, et al. Diabetes mellitus and risk of thyroid cancer: a meta‐analysis. PLoS One 2014;9(6):e98135
  4. Nagataki S, Nyström E. Epidemiology and primary prevention of thyroid cancer. Thyroid 2002;12(10):889‐96
  5. Satman I, Omer B, Tutuncu Y, et al. TURDEP‐II Study Group. Twelve‐year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169‐80
  6. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674‐85
  7. Tseng CH. Diabetes, metformin use, and colon cancer: A population based cohort study in Taiwan. Eur J Endocrinol 2012;167:409‐16
  8. Li H, Qian J. Association of diabetes mellitus with thyroid cancer risk: A meta‐analysis of cohort studies. Medicine (Baltimore). 2017;96(47):e8230
  9. Lo SF, Chang SN, Muo CH, et al. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 2013;132:182‐8
  10. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadóttir K, Tryggvadóttir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6:863‐73
  11. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15:548‐55
  12. Aschebrook‐Kilfoy B, Sabra MM, Brenner A. Diabetes and Thyroid Cancer Risk in the National Institutes of Health‐AARP Diet and Health Study. Thyroid 2011;21:957‐63
  13. Meinhold CL, Ron E, Schonfeld SJ, et al. Nonradiation Risk Factors for Thyroid Cancer in the US Radiologic Technologists Study. American Journal of Epidemiology 2009;171:242‐52
  14. Chen S‐T, Hsueh C, Chiou W‐K, Lin J‐D. Disease‐Specific Mortality and Secondary Primary Cancer in Well‐Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus. PLoS ONE 2013;8(1):e55179
  15. Tseng CH. Diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of Taiwanese. Eur J Clin Invest 2013;43(6):595‐601
  16. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U